|
Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy
RECRUITINGN/ASponsored by Erasmus Medical Center
Actively Recruiting
PhaseN/A
SponsorErasmus Medical Center
Started2026-07-22
Est. completion2027-12
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07435987
Summary
This prospective, non-randomised, single centre, phase I trial assesses the clinical feasibility of the use of the patient-tailored ARCHITECT applicator in locally advanced cervical cancer brachytherapy.
Eligibility
Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria: * Locally advanced cervical cancer (FIGO 2018 stage 1B3-IVA) with indication for primary radiotherapy including brachytherapy * Written informed consent Exclusion Criteria: * Unable to give informed consent; * Tumour extension in the lower 2/3rd of the vagina; * Requiring a Geneva tandem with ovoids' size 13 mm in the first application for brachytherapy; * Known nylon allergy.
Conditions3
CancerLocally Advanced Cervical CancerUterine Carcinoma
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorErasmus Medical Center
Started2026-07-22
Est. completion2027-12
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07435987